Neurology India
Open access journal indexed with Index Medicus
  Users online: 1245  
 Home | Login 
  About Current Issue Archive Ahead of print Search Instructions Online Submission Subscribe Etcetera Contact  
Read this article

 


    Article Cited by others

ORIGINAL ARTICLE

T2-weighted MRI in Parkinson’s disease; Substantia nigra pars compacta hypointensity correlates with the clinical scores

Atasoy Huseyin Tugrul, Nuyan Oguz, Tunc Tugba, Yorubulut Mehmet, Unal Aysun E, Inan Levent E

Year : 2004| Volume: 52| Issue : 3 | Page no: 332-337

   This article has been cited by
 
1 Clinical MRI for iron detection in Parkinsonęs disease
Rossi, M. and Ruottinen, H. and Soimakallio, S. and Elovaara, I. and Dastidar, P.
Clinical Imaging. 2013; 37(4): 631-636
[Pubmed]  [Google Scholar]
2 Progressive supranuclear palsy: High-field-strength MR microscopy in the human substantia nigra and globus pallidus
Foroutan, P. and Murray, M.E. and Fujioka, S. and Schweitzer, K.J. and Dickson, D.W. and Wszolek, Z.K. and Grant, S.C.
Radiology. 2013; 266(1): 280-288
[Pubmed]  [Google Scholar]
3 Does structural neuroimaging reveal a disturbance of iron metabolism in Parkinsonęs disease? Implications from MRI and TCS studies
Grƶger, A. and Berg, D.
Journal of Neural Transmission. 2012; 119(12): 1523-1528
[Pubmed]  [Google Scholar]
4 Brain iron accumulation in aging and neurodegenerative disorders
Hagemeier, J. and Geurts, J.J.G. and Zivadinov, R.
Expert Review of Neurotherapeutics. 2012; 12(12): 1467-1480
[Pubmed]  [Google Scholar]
5 Metal imaging in neurodegenerative diseases
Bourassa, M.W. and Miller, L.M.
Metallomics. 2012; 4(8): 721-738
[Pubmed]  [Google Scholar]
6 Correlation of subthalamic nuclei T2 relaxation times with neuropsychological symptoms in patients with Parkinsonęs disease
Watanabe, S. and Suenaga, K. and Yamamoto, A. and Abe, K. and Kotoura, N. and Ishikura, R. and Hirota, S. and Yoshikawa, H.
Journal of the Neurological Sciences. 2012; 315(1-2): 96-99
[Pubmed]  [Google Scholar]
7 Different iron-deposition patterns of multiple system atrophy with predominant parkinsonism and idiopathetic Parkinson diseases demonstrated by phase-corrected susceptibility-weighted imaging
Wang, Y. and Butros, S.R. and Shuai, X. and Dai, Y. and Chen, C. and Liu, M. and Haacke, E.M. and Hu, J. and Xu, H.B.
American Journal of Neuroradiology. 2012; 33(2): 266-273
[Pubmed]  [Google Scholar]
8 High resolution magnetic susceptibility mapping of the substantia nigra in Parkinsonęs disease
Lotfipour, A.K. and Wharton, S. and Schwarz, S.T. and Gontu, V. and SchƤfer, A. and Peters, A.M. and Bowtell, R.W. and Auer, D.P. and Gowland, P.A. and Bajaj, N.P.S.
Journal of Magnetic Resonance Imaging. 2012; 35(1): 48-55
[Pubmed]  [Google Scholar]
9 Acute and chronic metal exposure impairs locomotion activity in Drosophila melanogaster: A model to study Parkinsonism
Bonilla-Ramirez, L. and Jimenez-Del-Rio, M. and Velez-Pardo, C.
BioMetals. 2011; 24(6): 1045-1057
[Pubmed]  [Google Scholar]
10 Comparison of minimally invasive techniques in tongue base surgery in patients with obstructive sleep apnea
Babademez, M.A. and Yorubulut, M. and Yurekli, M.F. and Gunbey, E. and Baysal, S. and Acar, B. and Karaşen, R.M.
Otolaryngology - Head and Neck Surgery. 2011; 145(5): 858-864
[Pubmed]  [Google Scholar]
11 Assessment of metabolic changes in the striatum of a MPTP-intoxicated canine model: In vivo 1H-MRS study of an animal model for Parkinsonęs disease
Choi, C.-B. and Kim, S.-Y. and Lee, S.-H. and Jahng, G.-H. and Kim, H.-Y. and Choe, B.-Y. and Ryu, K.-N. and Yang, D.-M. and Yim, S.-V. and Choi, W.-S.
Magnetic Resonance Imaging. 2011; 29(1): 32-39
[Pubmed]  [Google Scholar]
12 Pathophysiology of transcranial sonography signal changes in the human substantia Nigra
Double, K.L. and Todd, G. and Duma, S.R.
International Review of Neurobiology. 2010; 90(C): 107-120
[Pubmed]  [Google Scholar]
13 The regional distribution of T2-relaxation times in MR images of the substantia nigra and crus cerebri
MƤnz, C. and Godau, J. and Berg, D. and Bender, B. and Ernemann, U. and Klose, U.
Neuroradiology. 2010; 52(8): 745-750
[Pubmed]  [Google Scholar]
14 Characterizing iron deposition in Parkinsonęs disease using susceptibility-weighted imaging: An in vivo MR study
Zhang, J. and Zhang, Y. and Wang, J. and Cai, P. and Luo, C. and Qian, Z. and Dai, Y. and Feng, H.
Brain Research. 2010; 1330: 124-130
[Pubmed]  [Google Scholar]
15 MR progress on excessive iron deposition in chronic nervous diseases
Miao, Y.-W. and Wu, J.-L.
Chinese Journal of Medical Imaging Technology. 2009; 25(11): 2129-2131
[Pubmed]  [Google Scholar]
16 Potential role of high-field MRI for studies in Parkinsonęs disease
Schuff, N.
Movement Disorders. 2009; 24(SUPPL.2): 1-2
[Pubmed]  [Google Scholar]
17 Determination of brain iron content in patients with Parkinsonęs disease using magnetic susceptibility imaging
Zhang, W., Sun, S.-G., Jiang, Y.-H., Qiao, X., Sun, X., Wu, Y.
Neuroscience Bulletin. 2009; 25(6): 1-2
[Pubmed]  [Google Scholar]
18 Variable-field relaxometry of iron-containing human tissues: A preliminary study
Hocq, A., Brouette, N., Saussez, S., Luhmer, M., Gillis, P., Gossuin, Y.
Contrast Media and Molecular Imaging. 2009; 4(4): 1-2
[Pubmed]  [Google Scholar]
19 Asymmetrical lateral ventricular enlargement in Parkinsonęs disease
Lewis, M.M., Smith, A.B., Styner, M., Gu, H., Poole, R., Zhu, H., Li, Y., (...), Huang, X.
European Journal of Neurology. 2009; 16(4): 1-2
[Pubmed]  [Google Scholar]
20 Expression and function of DMT1 without IRE in C6 cells mediated by recombinant adenovirus
Du, X., Xu, H., Jiang, H., Wang, J., Wang, L., Xie, J.
Frontiers of Medicine in China. 2009; 3(1): 1-2
[Pubmed]  [Google Scholar]
21 MRI assessment of basal ganglia iron deposition in Parkinsonęs disease
Wallis, L.I., Paley, M.N.J., Graham, J.M., Grünewald, R.A., Wignall, E.L., Joy, H.M., Griffiths, P.D.
Journal of Magnetic Resonance Imaging. 2008; 28(5): 1-2
[Pubmed]  [Google Scholar]
22 Contribution of disturbed iron metabolism to the pathogenesis of Parkinsonęs disease
Berg, D., Riederer, P., Gerlach, M.
Future Neurology. 2008; 3(4): 1-2
[Pubmed]  [Google Scholar]
23 Over-expressed human divalent metal transporter 1 is involved in iron accumulation in MES23.5 cells
Xu, H.-M., Jiang, H., Wang, J., Luo, B., Xie, J.-X.
Neurochemistry International. 2008; 52(6): 1-2
[Pubmed]  [Google Scholar]
24 Iron in Chronic Brain Disorders: Imaging and Neurotherapeutic Implications
Stankiewicz, J., Panter, S.S., Neema, M., Arora, A., Batt, C.E., Bakshi, R.
Neurotherapeutics. 2007; 4(3): 371-386
[Pubmed]  [Google Scholar]
25 An evaluation of distinct volumetric and functional MRI contributions toward understanding age and task performance: A study in the basal ganglia
Langenecker, S.A., Briceno, E.M., Hamid, N.M., Nielson, K.A.
Brain Research. 2007; 1135(1): 58-68
[Pubmed]  [Google Scholar]
26 Iron metabolism in parkinsonian syndromes
Berg, D., Hochstrasser, H.
Movement Disorders. 2006; 21(9): 1299-1310
[Pubmed]  [Google Scholar]
27 Magnetic resonance imaging of iron deposition in neurological disorders
Brass, S.D., Chen, N.-K., Mulkern, R.V., Bakshi, R.
Topics in Magnetic Resonance Imaging. 2006; 17(1): 31-40
[Pubmed]  [Google Scholar]
28 Role of iron in neurodegenerative disorders
Berg, D., Youdim, M.B.H.
Topics in Magnetic Resonance Imaging. 2006; 17(1): 5-17
[Pubmed]  [Google Scholar]

 

Online since 20th March '04
Published by Wolters Kluwer - Medknow